Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Rilogrotug by AVEO Pharmaceuticals for Metastatic Colorectal Cancer: Likelihood of Approval
Rilogrotug is under clinical development by AVEO Pharmaceuticals and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...
Data Insights
Rilogrotug by AVEO Pharmaceuticals for Metastatic Pancreatic Cancer: Likelihood of Approval
Rilogrotug is under clinical development by AVEO Pharmaceuticals and currently in Phase I for Metastatic Pancreatic Cancer. According to GlobalData,...